Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Diabetes in Developing Countries
Literature
1.
Von Haehling S, Doehner W, Anker SD. Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res. 2007;73:298–309.CrossRef
2.
Laviano A, Meguid MM, Inui A, Muscaritoli M, Fanelli FR. Therapy Insight: Cancer Anorexia−Cachexia Syndrome-When All You Can Eat Is Yourself. Nat Clin Pract Oncol. 2005;2:158–65.PubMedCrossRef
3.
Schwartz MW, Woods SC, Porte DJ, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404:661–71.PubMed
4.
Laviano A, Meguid MM, Rossi Fanelli F. Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies. Lancet Oncol. 2003;4:686–94.PubMedCrossRef
5.
Inui A. Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res. 1999;59:4493–501.PubMed
6.
Islam-Ali BS, Tisdale MJ. Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradation. Br J Cancer. 2001;84:1648–55.PubMedCrossRef
Metadata
Title
Cancer cachexia as a model for treatment of obesity
Authors
P. G. Raman
Adnan Z. Bootwala
Tehsin A. Petiwala
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
International Journal of Diabetes in Developing Countries / Issue 1/2012
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-011-0057-8

Other articles of this Issue 1/2012

International Journal of Diabetes in Developing Countries 1/2012 Go to the issue

Original Article

Performance of four risk scores for predicting insulin resistance in Thai adults

Original Article

Neutrophil Gelatinase-Associated Lipocalin (NGAL): an early marker for diabetic nephropathy

Editorial

Predicting type 2 diabetes mellitus and insulin resistance

Original Article

Spironolactone treatment in patients with diabetic microalbuminuria and resistant hypertension

Review Article

A clinical score to predict survival from hyperglycemic crisis following general medical wards admission in a resource constrained setting

Original Article

Macrosomic infants of nondiabetic and diabetic mothers: The challenges for obstetric practices in low resource community
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits